Overview

Kara Kuritz is a partner in Vinson & Elkins’ Antitrust practice. Her practice focuses on assessing antitrust risk in mergers and acquisitions, advising clients on how to navigate any antitrust risk, and working to ensure clients comply with US and global premerger notification requirements. Kara advocates on behalf of clients before the Federal Trade Commission, Antitrust Division of the Department of Justice, and state regulators in inquiries or investigations into mergers, acquisitions, or business conduct and policies. She also provides antitrust counseling on issues such as diligence and pre-closing conduct, information sharing, competitor collaborations, and interlocking directorates.

Read More

Experience

  • Global Partners on its acquisition of four operating, refined-products terminals from Gulf Oil Limited Partnership

  • Mach Natural Resources LP (NYSE: MNR) in a definitive agreement to acquire oil and gas assets located in the San Juan Basin from IKAV Energy Inc. for approximately $787 million in a cash-and-stock transaction

  • Sitio Royalties Corp. in its $4.1 billion merger with Viper Energy

  • Denbury Inc. in its $4.9 billion sale to ExxonMobil

  • PureWest Energy in its $1.84 billion merger with PW Picasso Buyer, a newly formed entity sponsored by a private consortium of family offices and financial institutions

  • Unanet and JMI Equity in its new round of strategic investment from Onex

  • Nutrabolt in its announced strategic partnership with Keurig Dr Pepper

  • PTC in its proposed acquisition of ServiceMax for approximately $1.46 billion

  • TA in its strategic growth investment in Technosylva

  • Acelyrin in its $300 million Series C financing round

  • Medical Properties Trust in its acquisition of Springstone for $950 million

  • Astorg Partners in its investment in the $500 million financing round of EcoVadis

  • Frazier Healthcare Partners in its sale of Parata Systems to Becton Dickinson & Co. for $1.525 billion

  • Clique Brands in its sale of Who What Wear to Future Publishing

  • ModeX Therapeutics in its sale to OPKO Health for $300 million

  • Biocon Biologics in its acquisition of Viatris for approximately $3.3 billion

  • CSafe Global in its acquisition of Softbox Systems

  • Innovium in its acquisition by Marvell Technology for $1.1 billion

  • G Squared in its $1.1 billion definitive business combination agreement with Transfix Inc.

Credentials

Education

  • George Mason University School of Law, J.D. cum laude, 2008
  • Washington & Jefferson College, B.A. summa cum laude, 2004

Admissions

  • District of Columbia
  • New York

Expand All

Recognitions

  • Legal 500 U.S., Antitrust: Merger Control, 2024–2026
  • Global Competition Review Award, 2025
  • Recommended Lawyer for Merger Control and FinTech by The Legal 500, 2021 and 2022
  • U.S. Department of Justice, The John Marshall Award for Outstanding Legal Achievement for Support of Litigation, 2019
  • U.S. Department of Justice, Antitrust Division Award of Distinction, 2015 and 2017
Insights

Client Alerts

Q2 2026 Healthcare Antitrust and Competition Update

The pace of policy initiatives, legislation, enforcement actions, and private litigation related to antitrust and competition in the healthcare sector …

August 24, 2026

August 24, 2026 • 14-minute read

Client Alerts

Q1 2026 Healthcare Antitrust and Competition Update

The healthcare sector accounts for an increasingly significant component of the U.S. economy. Healthcare spending constitutes 18.0 percent of U.S. …

May 19, 2026

May 19, 2026 • 11-minute read

Client Alerts

The HSR Act Applies to People Too: “Merger Control” Filing Obligations for Individual Investors, Family Offices, and Trusts

Every year, the U.S. Federal Trade Commission (“FTC”) investigates high net worth individuals for failure-to-file violations of the Hart-Scott-Rodino Antitrust …

May 6, 2026

May 6, 2026 • 8-minute read

Client Alerts

Back to the Old Form: FTC Resumes Prior HSR Regime Following Stay Denial

On March 19, 2026, the U.S. Court of Appeals for the Fifth Circuit denied the Federal Trade Commission’s (“FTC”) motion …

March 20, 2026

March 20, 2026 • 2-minute read

Event Recaps

Year in Review: Antitrust in the Energy & Chemicals Sectors

Jason Powers and Kara Kuritz discussed 2025 antitrust trends in the energy and chemicals industries and what lies ahead for companies in 2026.

January 20, 2026

January 20, 2026 • 1-minute read

Energy Series Background Decorative image
News & Achievements